Showing results (201-210 of 316) with videos related to

Sort By:
Pageof 32
Journal of Hepatology|December 19, 2024
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosisJose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, et al.
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
United European Gastroenterology Journal|July 19, 2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature reviewMiguel Eugenio Zoubek, José Pinazo-Bandera, Aida Ortega-Alonso, et al.
Gastroenterologia Y Hepatologia|January 22, 2026
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosisManuel Romero-Gómez, Javier Escalada, Mar Noguerol, et al.
Annals of Hepatology|January 8, 2013
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4Juan José Urquijo, Moisés Diago, Jaume Boadas, et al.
Journal of Clinical Medicine|September 4, 2020
Portal Thrombosis in Cirrhosis: Role of Thrombophilic DisordersJosé Ignacio Fortea, Inés García Carrera, Ángela Puente, et al.
Revista Espanola De Enfermedades Digestivas|February 28, 2019
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesityEsther Nistal, Luis E Sáenz de Miera, María Ballesteros Pomar, et al.
United European Gastroenterology Journal|August 5, 2024
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk populationPaula Iruzubieta, Rebeca Mayo, Itziar Mincholé, et al.
United European Gastroenterology Journal|November 28, 2023
No evidence of association between inherited thrombophilia and increased risk of liver fibrosisIranzu Ezcurra, Ángela Puente, Antonio Cuadrado, et al.
Pageof 32